Your browser doesn't support javascript.
loading
Brain alterations in Cocaine Use Disorder: Does the route of use matter and does it relate to the treatment outcome?
Poireau, Margaux; Segobin, Shailendra; Maillard, Angéline; Clergue-Duval, Virgile; Icick, Romain; Azuar, Julien; Volle, Emmanuelle; Delmaire, Christine; Bloch, Vanessa; Pitel, Anne-Lise; Vorspan, Florence.
Affiliation
  • Poireau M; Département de Psychiatrie et de Médecine Addictologique, Hôpital Fernand Widal, APHP.NORD, Paris, F-75010, France; INSERM UMR-S 1144 Therapeutic Optimization in Neuropsychopharmacology, Université Paris Cité, Paris, F-75006, France; FHU NOR-SUD (Network of Research in Substance Use Disorders), Pari
  • Segobin S; Normandie Univ, UNICAEN, PSL Université Paris, EPHE, INSERM, U1077, CHU de Caen, Cyceron, Neuropsychologie et Imagerie de la Mémoire Humaine (NIMH), 14000 Caen, France.
  • Maillard A; Département de Psychiatrie et de Médecine Addictologique, Hôpital Fernand Widal, APHP.NORD, Paris, F-75010, France; INSERM UMR-S 1144 Therapeutic Optimization in Neuropsychopharmacology, Université Paris Cité, Paris, F-75006, France.
  • Clergue-Duval V; Département de Psychiatrie et de Médecine Addictologique, Hôpital Fernand Widal, APHP.NORD, Paris, F-75010, France; INSERM UMR-S 1144 Therapeutic Optimization in Neuropsychopharmacology, Université Paris Cité, Paris, F-75006, France.
  • Icick R; Département de Psychiatrie et de Médecine Addictologique, Hôpital Fernand Widal, APHP.NORD, Paris, F-75010, France; INSERM UMR-S 1144 Therapeutic Optimization in Neuropsychopharmacology, Université Paris Cité, Paris, F-75006, France.
  • Azuar J; Département de Psychiatrie et de Médecine Addictologique, Hôpital Fernand Widal, APHP.NORD, Paris, F-75010, France; INSERM UMR-S 1144 Therapeutic Optimization in Neuropsychopharmacology, Université Paris Cité, Paris, F-75006, France.
  • Volle E; FRONT-Lab, ICM, Institut du Cerveau, Hôpital Pitié-Salpêtrière, 47 bd de l'Hôpital, 75013 Paris, France.
  • Delmaire C; INSERM UMR-S 1144 Therapeutic Optimization in Neuropsychopharmacology, Université Paris Cité, Paris, F-75006, France; Service de Neuroradiologie, Fondation Ophtalmologique Rothschild, 75019 Paris, France.
  • Bloch V; INSERM UMR-S 1144 Therapeutic Optimization in Neuropsychopharmacology, Université Paris Cité, Paris, F-75006, France; FHU NOR-SUD (Network of Research in Substance Use Disorders), Paris, France; Service de Pharmacie à Usage Intérieur, Hôpital Fernand Widal, APHP.NORD, Paris, France.
  • Pitel AL; Normandie Univ, UNICAEN, INSERM, PhIND "Physiopathology and Imaging of Neurological Disorders", Institut Blood and Brain @ Caen-Normandie, Cyceron, 14000 Caen, France; Institut Universitaire de France (IUF), France.
  • Vorspan F; Département de Psychiatrie et de Médecine Addictologique, Hôpital Fernand Widal, APHP.NORD, Paris, F-75010, France; INSERM UMR-S 1144 Therapeutic Optimization in Neuropsychopharmacology, Université Paris Cité, Paris, F-75006, France; FHU NOR-SUD (Network of Research in Substance Use Disorders), Pari
Psychiatry Res Neuroimaging ; 342: 111830, 2024 Aug.
Article in En | MEDLINE | ID: mdl-38820804
ABSTRACT

AIMS:

Cocaine Use Disorder (CUD) is an important health issue, associated with structural brain abnormalities. However, the impact of the route of administration and their predictive value for relapse remain unknown.

METHODS:

We conducted an anatomical MRI study in 55 CUD patients (26 CUD-Crack and 29 CUD-Hydro) entering inpatient detoxification, and 38 matched healthy controls. In patients, a 3-months outpatient follow-up was carried out to specify the treatment outcome status (relapser when cocaine was consumed once or more during the past month). A Voxel-Based Morphometry approach was used.

RESULTS:

Compared with controls, CUD patients had widespread gray matter alterations, mostly in frontal and temporal cortices, but also in the cerebellum and several sub-cortical structures. We then compared CUD-Crack with CUD-Hydro patients and found that crack-cocaine use was associated with lower volume in the right inferior and middle temporal gyri, and the right fusiform gyrus. Cerebellar vermis was smaller during detoxification in subsequent relapsers compared to three-months abstainers.

CONCLUSIONS:

Patients with CUD display widespread cortical and subcortical brain shrinkage. Patients with preferential crack-cocaine use and subsequent relapsers showed specific gray matter volume deficits, suggesting that different patterns of cocaine use and different clinical outcome are associated with different brain macrostructure.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain / Magnetic Resonance Imaging / Cocaine-Related Disorders / Gray Matter Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Psychiatry Res Neuroimaging Year: 2024 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain / Magnetic Resonance Imaging / Cocaine-Related Disorders / Gray Matter Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Psychiatry Res Neuroimaging Year: 2024 Document type: Article